.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Mallinckrodt
Fish and Richardson
Deloitte
Moodys
US Army
Cantor Fitzgerald
Farmers Insurance
Novartis
Federal Trade Commission

Generated: September 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075221

« Back to Dashboard
NDA 075221 describes ALFENTANIL, which is a drug marketed by Hospira and is included in one NDA. It is available from one supplier. Additional details are available on the ALFENTANIL profile page.

The generic ingredient in ALFENTANIL is alfentanil hydrochloride. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the alfentanil hydrochloride profile page.

Summary for NDA: 075221

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 075221

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 075221

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALFENTANIL
alfentanil hydrochloride
INJECTABLE;INJECTION 075221 ANDA Hospira, Inc. 0409-2266 0409-2266-49 10 AMPULE in 1 CARTON (0409-2266-49) > 2 mL in 1 AMPULE
ALFENTANIL
alfentanil hydrochloride
INJECTABLE;INJECTION 075221 ANDA Hospira, Inc. 0409-2266 0409-2266-51 10 AMPULE in 1 CARTON (0409-2266-51) > 5 mL in 1 AMPULE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 0.5MG BASE/ML
Approval Date:Oct 28, 1999TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Merck
Federal Trade Commission
Cipla
Novartis
Mallinckrodt
Deloitte
Accenture
US Department of Justice
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot